BARINOTTI, Alice
 Distribuzione geografica
Continente #
EU - Europa 570
NA - Nord America 562
AS - Asia 254
SA - Sud America 45
AF - Africa 9
OC - Oceania 3
Totale 1.443
Nazione #
US - Stati Uniti d'America 526
IT - Italia 269
SG - Singapore 87
CN - Cina 86
IE - Irlanda 84
ES - Italia 38
SE - Svezia 33
MX - Messico 28
RU - Federazione Russa 26
FR - Francia 23
DE - Germania 19
ID - Indonesia 19
GB - Regno Unito 13
IN - India 13
FI - Finlandia 12
BR - Brasile 11
AR - Argentina 9
RO - Romania 9
EC - Ecuador 8
PT - Portogallo 8
HU - Ungheria 7
JP - Giappone 7
TR - Turchia 7
HK - Hong Kong 6
IL - Israele 6
TW - Taiwan 6
CO - Colombia 5
PE - Perù 5
PL - Polonia 5
KR - Corea 4
MA - Marocco 4
NL - Olanda 4
RS - Serbia 4
AU - Australia 3
GR - Grecia 3
SA - Arabia Saudita 3
AM - Armenia 2
AT - Austria 2
BD - Bangladesh 2
BE - Belgio 2
BO - Bolivia 2
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HR - Croazia 2
LV - Lettonia 2
PH - Filippine 2
TN - Tunisia 2
VE - Venezuela 2
VN - Vietnam 2
CA - Canada 1
CU - Cuba 1
DK - Danimarca 1
EG - Egitto 1
GT - Guatemala 1
LT - Lituania 1
MY - Malesia 1
NI - Nicaragua 1
PK - Pakistan 1
UA - Ucraina 1
UY - Uruguay 1
Totale 1.443
Città #
Chandler 116
Dublin 84
Turin 70
Singapore 67
Sesto San Giovanni 59
Nyköping 32
New York 30
Ashburn 29
Torino 26
Jakarta 19
Medford 19
Rome 18
Milan 16
Hangzhou 13
Paris 13
Fairfield 12
Princeton 12
Santa Clara 12
Beijing 11
Hebei 10
Bologna 9
Madrid 9
Wilmington 9
Helsinki 8
Mexico City 8
Seattle 8
Cuenca 7
Falls Church 7
Lisbon 7
Guiyang 6
Bari 5
Berlin 5
Budapest 5
Chongqing 5
Mexico 5
Ravenna 5
San Diego 5
Valencia 5
Wroclaw 5
Acton 4
Ankara 4
Belgrade 4
Brescia 4
Bucaramanga 4
Bucharest 4
Córdoba 4
Delhi 4
Hyderabad 4
Lappeenranta 4
Padova 4
Seville 4
Athens 3
Barcelona 3
Carate Brianza 3
Chang-hua 3
Chengdu 3
Chicago 3
Cuauhtemoc 3
Guadalajara 3
Guangzhou 3
Houston 3
Jerusalem 3
Lima 3
Medina 3
Piazzola sul Brenta 3
Providence 3
Redwood City 3
Remedios de Escalada 3
Saint-Germain-en-Laye 3
Seoul 3
St Petersburg 3
São José dos Campos 3
Terrassa 3
Ulyanovsk 3
Wuhan 3
Zhengzhou 3
Allentown 2
Alvaro Obregon 2
Ararat 2
Blida 2
Boardman 2
Boston 2
Brussels 2
Campi Bisenzio 2
Caselle Torinese 2
Concon 2
Corato 2
Council Bluffs 2
Curitiba 2
Denver 2
Dhaka 2
Dong Ket 2
Essen 2
Fortaleza 2
Frankfurt am Main 2
Fuzhou 2
Genoa 2
Gustavo Adolfo Madero 2
Gwatt 2
Hammersmith 2
Totale 962
Nome #
Treatment of antiphospholipid syndrome 258
Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients 103
Clinical manifestations in patients with antiphospholipid antibodies: Beyond thrombosis and pregnancy loss 102
Improving the clinical accuracy in patients with antiphospholipid antibodies using anti-phosphatidylserine/prothrombin and anti-beta2 glycoprotein I domain and particle-based multi-analyte technology 82
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) 68
Genetic factors in antiphospholipid syndrome: Preliminary experience with whole exome sequencing 64
Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation 64
The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low-risk for chromosomal abnormalities 62
Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies 58
Iron Overload, Oxidative Stress, and Ferroptosis in the Failing Heart and Liver 55
Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study 53
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol 48
"How we treat" clinical dilemmas in antiphospholipid syndrome: A case-based approach 44
Validation of the particle-based multi-analyte technology for detection of anti-phosphatidylserine/ prothrombin antibodies 39
Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review 34
Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients 30
Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head 29
Disease activity at conception predicts lupus flare up to two years after birth: A multicentre long term follow-up study 29
Genetic Testing for a Patient with Suspected 3 Beta-Hydroxysteroid Dehydrogenase Deficiency: A Case of Unreported Genetic Variants 28
Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies 28
Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience 25
Renal Fibrosis in Lupus Nephritis 23
Finding the Needle in the Haystack: Serological and Urinary Biomarkers in Behçet’s Disease: A Systematic Review 21
Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App 20
Serum Biomarkers of Renal Fibrosis: A Systematic Review 19
2023 ACR/EULAR classification criteria in existing research cohorts: an international study 17
New Frontiers in Autoimmune Diagnostics: A Systematic Review on Saliva Testing 16
Reply to comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients 16
Assessing the steroid-sparing effect of biological agents in randomized controlled trials for lupus: a scoping review 13
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) (vol 122, pg 1612, 2022) 9
Thrombosis and APS: Lessons Learned from Another Black Swan Tale 8
Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology 8
Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab 8
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-β2GPI I domain 5
Pediatric Presentation of Antiphospholipid Syndrome: A Review of Recent Literature With Estimation of Local Prevalence 2
Quality of life measures in Systemic Lupus Erythematosus: A systematic review 2
Totale 1.490
Categoria #
all - tutte 7.182
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.182


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 5 0 1 2 2 5 2 4 8
2021/2022205 9 24 24 2 14 4 24 6 14 14 30 40
2022/2023558 40 45 23 43 61 113 46 39 39 20 60 29
2023/2024536 36 66 53 23 57 71 18 26 11 41 28 106
2024/2025162 37 59 43 23 0 0 0 0 0 0 0 0
Totale 1.490